Vonlanthen Group of Companies will be presenting a conference that includes a multitude of different subjects within the field of Inhalation and Respiratory Drug Development. We will be discussing how we develop and design dry powder inhalers; integrate development and scale-up combination products; patient use, compliance and human factors associated with DPIs; the challenges of developing a generic inhalant product; and the analytical approaches and specifications for inhaled medicine. Our panel will be addressing these critical issues and much more over the two days, to drive new concepts and new ways of thinking among a consortium of different companies and people in the field of Respiratory and Inhalation Drug/Product Development.
We hope to see you in Berlin this coming September 2017!
Key Practical Learning Points of the Summit:
Who Should Attend:
Directors, Vice Presidents, Managers and Department Heads specialising in:
Please, complete details below:
Please, complete details below and you will get Agenda via E-mail:
Please, complete details below and you will get 500 € Document Package: